Investment and innovation key to PharmX growth

Pharmacy ordering platform eyes continued growth after posting strong results for the financial year 2025  PharmX is aiming to build on the momentum established in FY25, with the company reporting revenue growth of 13% for the year to 30 June 2025.  Unveiling its annual results to the Australian Securities Exchange (ASX) this morning (Wednesday 20